Yoon K, Chu K, Eom G, Mao J, Quan F
PLoS Negl Trop Dis. 2024; 18(6):e0012229.
PMID: 38857253
PMC: 11164348.
DOI: 10.1371/journal.pntd.0012229.
Vojtkova B, Spitzova T, Votypka J, Lestinova T, Kominkova I, Hajkova M
Microorganisms. 2020; 8(9).
PMID: 32962237
PMC: 7563294.
DOI: 10.3390/microorganisms8091440.
Saini S, Dube A, Sahasrabuddhe A, Thakur C, Joshi S, Rawat K
Acta Parasitol. 2019; 65(1):57-67.
PMID: 31578670
DOI: 10.2478/s11686-019-00127-8.
Joice A, Yang S, Farahat A, Meeds H, Feng M, Li J
Antimicrob Agents Chemother. 2017; 62(1).
PMID: 29061761
PMC: 5740383.
DOI: 10.1128/AAC.01129-17.
Naqvi N, Ahuja K, Selvapandiyan A, Dey R, Nakhasi H, Puri N
Sci Rep. 2017; 7(1):13240.
PMID: 29038500
PMC: 5643406.
DOI: 10.1038/s41598-017-12753-1.
Leishmania eukaryotic initiation factor (LeIF) inhibits parasite growth in murine macrophages.
Koutsoni O, Barhoumi M, Guizani I, Dotsika E
PLoS One. 2014; 9(5):e97319.
PMID: 24830439
PMC: 4022710.
DOI: 10.1371/journal.pone.0097319.
Animal models for the study of leishmaniasis immunology.
Loria-Cervera E, Andrade-Narvaez F
Rev Inst Med Trop Sao Paulo. 2014; 56(1):1-11.
PMID: 24553602
PMC: 4085833.
DOI: 10.1590/S0036-46652014000100001.
Experimental models in vaccine research: malaria and leishmaniasis.
Teixeira C, Gomes R
Braz J Med Biol Res. 2013; 46(2):109-16.
PMID: 23369975
PMC: 3854354.
DOI: 10.1590/1414-431x20122460.
Evasion of Host Defence by Leishmania donovani: Subversion of Signaling Pathways.
Shadab M, Ali N
Mol Biol Int. 2011; 2011:343961.
PMID: 22091401
PMC: 3199940.
DOI: 10.4061/2011/343961.
Restoration of IFNγR subunit assembly, IFNγ signaling and parasite clearance in Leishmania donovani infected macrophages: role of membrane cholesterol.
Sen S, Roy K, Mukherjee S, Mukhopadhyay R, Roy S
PLoS Pathog. 2011; 7(9):e1002229.
PMID: 21931549
PMC: 3169561.
DOI: 10.1371/journal.ppat.1002229.
Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes.
Halstead S, Mahalingam S, Marovich M, Ubol S, Mosser D
Lancet Infect Dis. 2010; 10(10):712-22.
PMID: 20883967
PMC: 3057165.
DOI: 10.1016/S1473-3099(10)70166-3.
Leishmania interferes with host cell signaling to devise a survival strategy.
Bhardwaj S, Srivastava N, Sudan R, Saha B
J Biomed Biotechnol. 2010; 2010:109189.
PMID: 20396387
PMC: 2852600.
DOI: 10.1155/2010/109189.
Characterization of Leishmania isolates from Nepalese patients with visceral leishmaniasis.
Pandey K, Yanagi T, Pandey B, Mallik A, Sherchand J, Kanbara H
Parasitol Res. 2007; 100(6):1361-9.
PMID: 17310397
DOI: 10.1007/s00436-007-0464-4.
Antagonizing deactivating cytokines to enhance host defense and chemotherapy in experimental visceral leishmaniasis.
Murray H, Flanders K, Donaldson D, Sypek J, Gotwals P, Liu J
Infect Immun. 2005; 73(7):3903-11.
PMID: 15972476
PMC: 1168607.
DOI: 10.1128/IAI.73.7.3903-3911.2005.
Comparative activities of the triterpene saponin maesabalide III and liposomal amphotericin B (AmBisome) against Leishmania donovani in hamsters.
Maes L, Germonprez N, Quirijnen L, Van Puyvelde L, Cos P, Vanden Berghe D
Antimicrob Agents Chemother. 2004; 48(6):2056-60.
PMID: 15155199
PMC: 415622.
DOI: 10.1128/AAC.48.6.2056-2060.2004.
In vivo involvement of polymorphonuclear neutrophils in Leishmania infantum infection.
Rousseau D, Demartino S, Ferrua B, Michiels J, Anjuere F, Fragaki K
BMC Microbiol. 2001; 1:17.
PMID: 11591218
PMC: 57739.
DOI: 10.1186/1471-2180-1-17.
Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis.
Melby P, Yang J, Zhao W, Perez L, Cheng J
Infect Immun. 2001; 69(8):4719-25.
PMID: 11447143
PMC: 98557.
DOI: 10.1128/IAI.69.8.4719-4725.2001.
Identification of vaccine candidates for experimental visceral leishmaniasis by immunization with sequential fractions of a cDNA expression library.
Melby P, Ogden G, Flores H, Zhao W, Geldmacher C, Biediger N
Infect Immun. 2000; 68(10):5595-602.
PMID: 10992459
PMC: 101511.
DOI: 10.1128/IAI.68.10.5595-5602.2000.
Modulation of CD11C+ splenic dendritic cell functions in murine visceral leishmaniasis: correlation with parasite replication in the spleen.
Basu A, Chakrabarti G, Saha A, Bandyopadhyay S
Immunology. 2000; 99(2):305-13.
PMID: 10692051
PMC: 2327141.
DOI: 10.1046/j.1365-2567.2000.00939.x.
Short- and long-term efficacy of hexadecylphosphocholine against established Leishmania infantum infection in BALB/c mice.
Le Fichoux Y, Rousseau D, Ferrua B, Ruette S, Lelievre A, Grousson D
Antimicrob Agents Chemother. 1998; 42(3):654-8.
PMID: 9517947
PMC: 105513.
DOI: 10.1128/AAC.42.3.654.
